Cyclobenzaprine in Muscle Cramps With Liver Cirrhosis
NCT02642861 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2018-01-03
Summary
\- Cyclobenzaprine, is a muscle relaxer medication used to relieve skeletal muscle spasms. It is one of the best-studied drug for this application.
Conditions
Interventions
- DRUG
-
Cyclobenzaprine
cyclobenzaprine administration for 2 weeks
- DRUG
-
Calcium Carbonate
Calcium carbonate for 2 weeks
Sponsors & Collaborators
-
Tanta University
lead OTHER
Principal Investigators
-
Sherief M. Abd-Elsalam, Consultant · liver diseases dept.- Tanta university hospital
-
Walaa A. Elkhalawany, Consultant · liver diseases dept.- Tanta university hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-31
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- Egypt
Study Locations
More Related Trials
-
The Use of Botulinum Toxin in the Management of Myofascial Pain Syndrome
NCT06824324 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparison of Botulinum Toxin Injection Techniques in Spasticity
NCT05615987 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm
NCT00942851 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intracavernosal Injection of Botulinum Toxin Type A in the Treatment of Vascular Erectile Dysfunction
NCT02584686 ·Status: COMPLETED ·Phase: PHASE1
-
Early Use of Botulinum Toxin in Spasticity Post Stroke.
NCT01882556 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Two Botulinum Type A Products in the Treatment of Blepharospasm
NCT00761592 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia
NCT02604186 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Botulinum Toxin on Muscles of Children With Cerebral Palsy
NCT02853240 ·Status: COMPLETED ·Phase: NA
-
Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Participants With Spasticity Associated With Cerebral Palsy
NCT06150729 ·Status: COMPLETED
-
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
NCT01603459 ·Status: COMPLETED ·Phase: PHASE3
-
Muscle Selection for Botulinum Toxin A Injection in Poststroke Elbow Flexor Spasticity
NCT04036981 ·Status: COMPLETED
-
Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis
NCT03048383 ·Status: COMPLETED ·Phase: PHASE4
-
Mandibular Splint vs Botox Injection in Lateral Pterygoid on Cervical Muscle Activity in Patients With Temporomandibular Disorders
NCT06553950 ·Status: RECRUITING ·Phase: NA
-
Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity
NCT05956509 ·Status: TERMINATED ·Phase: PHASE1
-
Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain
NCT00178945 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Performance of Therapeutic Use of BTX for Bruxism
NCT06258070 ·Status: COMPLETED ·Phase: NA
-
Botox vs. Baclofen for Upper Limb Spasticity
NCT00280280 ·Status: TERMINATED ·Phase: PHASE1
-
Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm
NCT01546805 ·Status: UNKNOWN ·Phase: NA
-
Cryoneurolysis for Spasticity Treatment: Long-term Clinical Outcomes and Mechanisms in the Central Nervous System
NCT06958289 ·Status: RECRUITING ·Phase: NA
-
Botulism Antitoxin Effects on Paralysis Induced by Botulinum Neurotoxins in the EDB Muscle
NCT00636519 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Evaluation of the Efficacy OF Botulinum Toxin A for Improving Facial Scars
NCT04756882 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
OnabotulinumtoxinA in the Management of Psychogenic Dystonia
NCT02618889 ·Status: COMPLETED ·Phase: PHASE4
-
Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines
NCT00430586 ·Status: COMPLETED ·Phase: PHASE2
-
The Therapeutic Use of Botulinum Toxin Type A in Subacute Cervical/Upper Back Pain
NCT00282958 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Botulinum Toxin A in the Treatment of Bruxism-related Symptomatology
NCT04722809 ·Status: TERMINATED ·Phase: PHASE3